Biocon Limited operates in the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Biocon Limited with three other
pharmaceutical manufacturers in Asia:
sales of 2.47 billion Japanese Yen [US$21.57 million]
of which 64%
was Health Inspection Equipment),
Panacea Biotec Ltd
(6.53 billion Indian Rupees [US$95.74 million]
of which 59%
was Formulation), and
Pharma Foods International Co.Ltd
based in Japan
(3.46 billion Japanese Yen [US$30.18 million]
of which 60%
was Functional product(Online business)).
Biocon Limited reported sales of 34.85 billion Indian Rupees (US$510.96 million)
March of 2016.
increase of 12.8%
versus 2015, when the company's sales were 30.90 billion Indian Rupees.
This was the fourth straight year of sales growth at Biocon Limited.
Sales of Research Services saw an increase
that was more than double the company's growth rate: sales were up
28.8% in 2016, from
8.40 billion Indian Rupees to 10.81 billion Indian Rupees.